(Q42268964)

19 October 2017

title

Vindesine therapy in melphalan-resistant multiple myeloma (English)

1 reference

19 October 2017

B. Houwen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7262159

3 April 2024

T. Ockhuizen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7262159

3 April 2024

J. Marrink

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7262159

3 April 2024

H. O. Nieweg

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7262159

3 April 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7262159

3 April 2024

publication date

1 February 1981

1 reference

full work available at URL

19 October 2017

https://api.elsevier.com/content/article/PII:0014296481900402?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0014-2964(81)90040-2

https://api.elsevier.com/content/article/PII:0014296481900402?httpAccept=text/plain

3 April 2024

1 reference

https://api.crossref.org/works/10.1016/0014-2964(81)90040-2

European Journal of Cancer

3 April 2024

published in

1 reference

19 October 2017

volume

17

1 reference

19 October 2017

issue

2

1 reference

19 October 2017

page(s)

227-232

1 reference

Combination therapy for multiple myeloma

19 October 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0014-2964(81)90040-2

Chemotherapy for multiple myeloma

3 April 2024

3

1 reference

https://api.crossref.org/works/10.1016/0014-2964(81)90040-2

Combination chemotherapy of multiple myeloma with Alkeran, Cytoxan, vincristine, prednisone, and BCNU

3 April 2024

4

1 reference

https://api.crossref.org/works/10.1016/0014-2964(81)90040-2

Clinical pharmacokinetics of vindesine

3 April 2024

6

1 reference

https://api.crossref.org/works/10.1016/0014-2964(81)90040-2

Phase-II trial with vindesine for regression induction in patients with leukemias and hematosarcomas

3 April 2024

7

1 reference

https://api.crossref.org/works/10.1016/0014-2964(81)90040-2

Vindesine in the treatment of breast cancer

3 April 2024

8

1 reference

https://api.crossref.org/works/10.1016/0014-2964(81)90040-2

Comparative effects of vincristine and vindesine on cell cycle kinetics in vitro

3 April 2024

11

1 reference

https://api.crossref.org/works/10.1016/0014-2964(81)90040-2

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

3 April 2024

12

1 reference

https://api.crossref.org/works/10.1016/0014-2964(81)90040-2

Combination chemotherapy for multiple myeloma

3 April 2024

15

1 reference

https://api.crossref.org/works/10.1016/0014-2964(81)90040-2

3 April 2024

Identifiers

1 reference

19 October 2017

1 reference